Evaluation of prostate specific antigen (PSA) response following abiraterone in metastatic, castration resistant prostate cancer (mCRPC) previously treated with ketoconazole compared to ketoconazole naïve patients: A retrospective review.

Sofia Ghani,Kristopher Attwood,Angie Elefante,Kanza Khalid,Donald L. Trump

Evaluation of prostate specific antigen (PSA) response following abiraterone in metastatic, castration resistant prostate cancer (mCRPC) previously treated with ketoconazole compared to ketoconazole naïve patients: A retrospective review.

2014

Sofia Ghani
Kristopher Attwood
Angie Elefante
Kanza Khalid
Donald L. Trump

e16067 Background: There is persuasive evidence that castration resistant prostate cancer (CRPC) remains AR dependent. Ketoconazole and abiraterone, block adrenal/intratumoral androgen biosynthesis...

Keywords:

Abiraterone
Prostate-specific antigen
Prostate cancer
Pathology
Ketoconazole
Castration
Cancer research
Medicine
Oncology
previously treated
retrospective review
therapy naive
Internal medicine
castration resistant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations